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Three techniques for the treatment of intractable pancreatic ﬁstula: percutaneous transﬁstulous pancreatic duct drainage (PTPD),
percutaneous transﬁstulous pancreatojejunostomy (PTPJ), and percutaneous transﬁstulous pancreatic duct embolization (PTPE)
are presented as treatment options for intractable pancreatic ﬁstula. PTPD is eﬀective for most cases of intractable ﬁstula that
communicate with the main pancreatic duct. However, PTPD itself is not enough in some speciﬁc cases. PTPJ and PTPE are
applicable in such cases.
1.Introduction
Pancreatic ﬁstula (PF) remains a signiﬁcant problem in the
management of pancreatectomy. Despite decreased mor-
bidity and mortality rates after pancreatic resection, PF
remains a common and potentially lethal complication after
pancreatectomy. Its reported incidence varies from 6 to 38%
[1–7]. If PF occurs, the pancreatic juice must be drained
externally to avoid the development of intra-abdominal
hemorrhage and sepsis. Eighty ﬁve to 95% of PF can be
managed by a combination of external drainage and medical
therapy [3, 8]. However, occasional patients with inadequate
treatment may require further advanced treatments.
PF also sometimes becomes a signiﬁcant problem in
severe acute pancreatitis. Pseudocysts and postnecrotic
collections of the pancreas are treated by percutaneous
drainage if they are large and likely to aggravate the patients’
condition. Approximately 65–90% of patients recover from
thisdiseasebypercutaneousdrainagealone[9–12].However,
recovery is often diﬃcult if the main pancreatic duct is
injured [9, 10].
Techniques of percutaneous transﬁstulous drainage of
the main pancreatic duct (percutaneous transﬁstulous pan-
creatic duct drainage: PTPD) for intractable PF cases are
presented. Furthermore, percutaneous transﬁstulous pan-
creatojejunostomy (PTPJ) and percutaneous transﬁstulous
pancreatic duct embolization (PTPE) are also presented as
advanced techniques of PTPD.
2. Techniques
2.1. Percutaneous Transﬁstulous Pancreatic Duct Drainage
(PTPD). This technique is useful for major PF in which the
main pancreatic duct is visualized in ﬁstulography [13, 14].
Any abscess due to PF is ﬁrst drained percutaneously. An
angled angiography catheter (RIM or RC2, Medikit, Tokyo)
is inserted into the main pancreatic duct via the injured site
(Figure 1). By twisting and taking the catheter in and out of
the ﬁstula, the route into the pancreatic duct can be selected.
The abscess drainage tube can be used as a sheath of the
catheter. After placing the catheter into the main pancreatic
duct, the abscess content is drained using another catheter.
Because almost all pancreatic juice drained externally with
this system, the abscess is cured within a short period.
2.2.PercutaneousTransﬁstulousPancreatojejunostomy(PTPJ).
When intractable PF is developed after pancreatoduodenec-
tomy, abscess around the pancreatojejunostomy is drained
percutaneously at ﬁrst. Then, drainage catheters are inserted
into the pancreatic duct (PTPD procedure) and jejunum,
respectively. A guidewire is inserted into the jejunum via
percutaneoustransﬁstulousroutethroughthedrainagetube.
The guidewire, grasped by a basket catheter inserted from
thepercutaneoustranshepaticbiliarydrainage(PTBD)route
under ﬂuoroscopy, is led externally via the PTBD outlet
(Figures 2(a) and 2(b)). Finally, a drainage catheter is2 Radiology Research and Practice
Figure 1: Percutaneous transﬁstulous pancreatic duct drainage (PTPD). Using the abscess drainage tube as a sheath, an angled catheter is
inserted into the main pancreatic duct.
(a) (b)
(c) (d)
Figure 2: Percutaneous transﬁstulous pancreatojejunostomy (PTPJ). Firstly, abscess around the pancreatojejunostomy is drained
percutaneously. Then, drainage catheters are inserted into the pancreatic duct (PTPD procedure) and jejunum, respectively. A guide wire
inserted into the jejunum via the drainage tube is grasped by a basket catheter and led externally from percutaneous transhepatic biliary
drainage (PTBD) route (a and b). A drainage catheter is inversely inserted into the remnant pancreatic duct over the guide wire (c and d).Radiology Research and Practice 3
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Figure 3: Percutaneous transﬁstulous pancreatic duct embolization (PTPE). Large postnecrotic collection is formed owing to disruption of
the main pancreatic duct at the body (a and b). The upstream pancreatic duct is inserted with a drainage catheter (PTPD procedure) (c and
d) and is injected with prolamine via the catheter under microscopy.
inversely inserted into the remnant pancreatic duct over the
guidewire via the PTBD route and the jejunum (Figures 2(c)
and 2(d)). The position of the drainage catheter is adjusted
by pulling a thread placed on its tip through abscess drainage
outlet.Pancreaticjuicethenﬂowsalongthedrainagecatheter
from the pancreas to outside of the body via the jejunum
and intrahepatic bile duct. After one month, the drainage
catheter is removed, and PTPJ is established [13].
2.3. Percutaneous Transﬁstulous Pancreatic Duct Embolization
(PTPE). Large postnecrotic collection can be formed owing
to disruption of the main pancreatic duct in some severe
necrotizing acute pancreatitis (Figures 3(a) and 3(b)). In
such cases, PF may be intractable. We radically treat such
PF by selective drainage of the upstream pancreatic duct via
the damaged site of the pancreatic duct (PTPD procedure)
(Figures 3(c) and 3(d)). The upstream pancreatic duct
is embolized with prolamine (Ethibloc, Ethicon GmbH,
Norderstedt, Germany) under ﬂuoroscopy to extinguish the
exocrine function of the caudal pancreas (PTPE procedure).
Prolamine is a gel that hardens within minutes when it
contacts with water. It has been used for the embolization
of the pancreatic duct to prevent the development of PF after
resection or transplantation of the pancreas [15, 16]. The PF
can be cured by several PTPE procedures [14].
3. Discussion
PF represents clinically relevant complications with life-
threateningconsequences(i.e.,bleeding,sepsis)afterpancre-
atic resection and in acute necrotizing pancreatitis. PTPD,
PTPJ, and PTPE are presented as treatment options for
intractable PF. Visualization of the main pancreatic duct
during ﬁstulography indicates that the PF is intractable.
The conventional treatment strategy for PF consists of
establishing adequate external drainage, treating infection,
providing nutritional support, and reducing pancreatic juice
secretionbyparenteralnutritionoroctreotide.Witheﬀective
drainage, most of the PF can be cured by conservative
treatment. However, the management of intractable PF
cases has not been standardized and remains challeng-
ing. The management of intractable PF is individualized.4 Radiology Research and Practice
Severalprocedureshavebeenreported,includingendoscopic
drainage, percutaneous intervention [13], and surgical treat-
ment such as completion pancreatectomy. Occlusion of the
pancreatic duct has also been performed using tissue glues,
such as prolamine, ethylene-vinyl alcohol, and ﬁbrin glue
[14, 17]. The vast majority of PFs, which are characterized by
maintained continuity with an unobstructed main pancre-
aticduct(sideﬁstula)respondwelltoconservativetreatment
[18]. However, PFs that lose continuity with the downstream
(end ﬁstula) do not respond to conservative treatment.
Transpapillary stents can bypass the high resistance of
the sphincter of Oddi, ductal strictures, and calculi, thereby
reducing the intraductal pressure that is the driving force
behind the ﬁstula. Endoscopic pancreatic sphincterotomy is
also recommended for the treatment of PF after DP [17].
However, the communication routes between the duodenum
and pancreatic duct that are created by these procedures
may sometimes exaggerate infection. From this standpoint,
percutaneous transﬁstulous drainage (PTPD procedure), if
possible, is preferable.
Innecrotizingpancreatitis,disruptionofmainpancreatic
duct appears to be associated with the most severe form
of necrosis [19, 20]. Uomo et al. [21] reported that the
incidence of main pancreatic duct injury is 31%. If the
main pancreatic duct is injured in necrotizing pancreatitis,
intractable PF may be developed. Such conditions are often
diﬃcult to treat. However, drainage of the distal pancreatic
duct using an angiographic catheter under ﬂuoroscopy
(PTPD procedure) followed by extinction of the exocrine
function of the distal pancreas by PTPE is highly eﬀective
in treating intractable PF even in such cases. Such condition
may be the most appropriate indication of PTPE.
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